Please login to the form below

Not currently logged in
Email:
Password:

Antibody testing

This page shows the latest Antibody testing news and features for those working in and with pharma, biotech and healthcare.

PHE study finds people who have had COVID-19 can still transmit the virus

PHE study finds people who have had COVID-19 can still transmit the virus

The SIREN study has been regularly performing antibody and PCR testing on healthcare workers from 102 NHS trusts since June 2020. ... The study found that antibody protection after infection lasts for at least five months on average, although the

Latest news

  • Eli Lilly’s COVID-19 antibody trial paused due to safety issue Eli Lilly’s COVID-19 antibody trial paused due to safety issue

    Lilly is also testing the antibody treatment as a preventative therapy for nursing home residents and workers who may have been exposed to the virus. ... Lilly has since confirmed the OAI notice but said that the data deletions were unrelated to the COVID

  • Britain ramps up COVID-19 testing to track spread of infections Britain ramps up COVID-19 testing to track spread of infections

    Regular testing will increase from 28, 000 people per fortnight to 150, 000 by October. ... restrictions. The survey, co-led by the ONS and The University of Oxford, will use routine swabbing and antibody testing to provide key insights into the rate of

  • Speed kills Speed kills

    From testing to reopening to vetting scientific articles, we have lost track of time. ... Diagnostic and antibody testing has not been excluded from this obsession with velocity either.

  • Delivering safe and effective clinical trials during the COVID-19 pandemic Delivering safe and effective clinical trials during the COVID-19 pandemic

    Secondly, we used antibody testing to establish whether there had already been mild infections; none were detected. ... This ensures that we do not miss asymptomatic infections. We have implemented accurate antibody testing (RAPG-COV-019) that indicates

  • Almirall eyes $62m takeover of multicytokine specialist Bioniz Almirall eyes $62m takeover of multicytokine specialist Bioniz

    BNZ-1 a selective and simultaneous inhibitor of cytokines IL-2, IL-9 and IL-15 which is in early-stage testing for CTCL and also has potential for alopecia areata, ... The option deal comes amid an expansionist phase for Almirall, which exercised an

More from news
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    AbbVie is testing its anti-tau antibody ABBV-8E12 in a phase 2 trial, while Biogen has links to two midphase tau programmes. ... The big biotech is testing its own BIIB092 in early Alzheimer’s patients and has an option to develop an Ionis

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics